Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab by Tol, Jolien, Dijkstra, Jeroen R, Klomp, Marjolein, Teerenstra, Steven, Dommerholt, Martin, Vink-Börger, M. Elisa, van Cleef, Patricia H, van Krieken, J. Han, Punt, Cornelis J.A, Nagtegaal, Iris D

Get full text